Redefining ‘success’: a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization

医学 荟萃分析 血运重建 内科学 外科 心肌梗塞
作者
Asim Rizvi,Seyed Mohammad Seyedsaadat,M. Hassan Murad,Waleed Brinjikji,Seán Fitzgerald,Ramanathan Kadirvel,Alejandro A. Rabinstein,David F. Kallmes
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:11 (1): 9-13 被引量:55
标识
DOI:10.1136/neurintsurg-2018-013950
摘要

Background Conventionally, ‘successful’ endovascular thrombectomy (EVT) had been defined as achieving revascularization of thrombolysis in cerebral infarction (TICI)−2B or greater, rather than as ‘complete’ (TICI-3) versus ‘incomplete’ (TICI-2B) revascularization. Purpose We performed a systematic review and meta-analysis of studies comparing clinical outcomes between patients with TICI-2B and TICI-3 revascularization. Methods Multiple databases were searched for relevant publications between January 2003 and March 2018. Studies comparing outcomes between the TICI-2B and the TICI-3 group of acute ischemic stroke (AIS) patients treated with EVT were included. Random effects meta-analysis was performed to evaluate outcomes among TICI-2B and TICI-3 groups. The following outcomes were assessed: good neurologic outcome (modified Rankin Scale (mRS)≤2 at day 90), mortality, and intracerebral hemorrhage (ICH). Results Twenty-one studies comprising 2747 patients were identified. Patients with TICI-2B revascularization had mRS≤2 at day 90 rates of 46% (391/847) compared with 66% (522/791) for TICI-3 patients (OR 0.46, 95% CI 0.37 to 0.57). Mortality rates were significantly higher in the TICI-2B group (78/570, 14%) than in the TICI-3 group (55/709, 8%) (OR 2.00, 95% CI 1.38 to 2.91). The ICH rates were also significantly higher in the TICI-2B group as compared with the TICI-3 group (31% [134/439] vs. 22% [108/490]; OR 2.20, 95% CI 1.47 to 3.30). Conclusions Differences in all major outcome measures were markedly better in patients with complete versus incomplete but still ‘successful’ revascularization using prior thresholds, with ORs in the order of those seen in recent definitive trials comparing EVT to an intravenous tissue plasminogen activator.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
情怀应助顺心人达采纳,获得10
2秒前
霍焱发布了新的文献求助10
3秒前
科研通AI6.1应助Dr.c采纳,获得10
6秒前
碧蓝的安露完成签到 ,获得积分10
7秒前
hhhhxxxx完成签到,获得积分10
9秒前
11秒前
陈豆豆完成签到 ,获得积分10
12秒前
甜甜凉面完成签到,获得积分10
13秒前
懵懂的梦秋完成签到,获得积分10
13秒前
L_chen发布了新的文献求助10
14秒前
李爱国应助zl987采纳,获得10
16秒前
18秒前
Henry完成签到,获得积分10
18秒前
estrella完成签到 ,获得积分10
19秒前
句灼完成签到,获得积分10
20秒前
kevinqpp发布了新的文献求助10
22秒前
22秒前
L_chen完成签到,获得积分20
22秒前
27秒前
27秒前
28秒前
28秒前
28秒前
28秒前
28秒前
科研通AI6应助科研通管家采纳,获得10
28秒前
Ava应助科研通管家采纳,获得10
28秒前
科研通AI6应助科研通管家采纳,获得10
28秒前
Adc应助科研通管家采纳,获得10
28秒前
Ava应助科研通管家采纳,获得10
28秒前
Adc应助科研通管家采纳,获得10
28秒前
freebird应助科研通管家采纳,获得10
28秒前
量子星尘发布了新的文献求助10
28秒前
英姑应助科研通管家采纳,获得10
28秒前
田様应助科研通管家采纳,获得30
28秒前
28秒前
马迦南完成签到 ,获得积分10
29秒前
kimiwanano完成签到,获得积分10
29秒前
盼盼完成签到,获得积分10
31秒前
Dr.c发布了新的文献求助10
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
从k到英国情人 1500
Ägyptische Geschichte der 21.–30. Dynastie 1100
„Semitische Wissenschaften“? 1100
Real World Research, 5th Edition 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5733153
求助须知:如何正确求助?哪些是违规求助? 5346222
关于积分的说明 15323096
捐赠科研通 4878315
什么是DOI,文献DOI怎么找? 2621157
邀请新用户注册赠送积分活动 1570280
关于科研通互助平台的介绍 1527163